IRVINE, Calif., Oct. 23, 2023 (GLOBE NEWSWIRE) — Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN) today announced the appointment of Eliezer Katz, M.D., FACS as Chief Medical Officer with responsibility for leading the company’s clinical development programs. “We are pleased to welcome Dr. Katz to the Eledon team,” said David-Alexandre C.…Read More
Eledon Pharmaceuticals Inc Eledon Pharmaceuticals Strengthens Leadership Team with Appointment of Eliezer Katz MD FACS as Chief Medical Officer
